GLP-1 medicines carry a warning about thyroid C-cell tumours based on rodent studies
In the literature, I dont think that there is a strong association as of yet, but clinically we are definitely seeing a lot of patients in practice either with telogen effluvium or androgenetic alopecia, which we do believe is somehow being caused by the use of these medications, Nusbaum said
For personalized guidance and treatment plans tailored to your needs, visit Dr
Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia
Elecoglipron is an oral small molecule GLP-1 RA (receptor agonist), Vanita Aroda, MD, director of Diabetes Clinical Research at Brigham and Womens Hospital, associate professor of medicine at Harvard Medical School, and lead author of this study, told Medical News Today
Published Scientific Research Peer-reviewed laboratory studies investigating growth hormone peptides The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration